Synthetic data only. Never enter patient information; nothing is sent or stored. For clinicians. Not FDA cleared.For licensed clinicians. Educational demonstration on synthetic data. Never enter real patient identifiers or protected health information: everything runs in your browser and nothing is sent or stored. Clinical decision support only; not FDA cleared; physician review is required.
CPE-004 · Context triggers
ID-CKD-01: Chronic kidney disease with anemia
Chronic kidney disease with anemia. Evaluates CKD documented.
Active rulePriority 4Iron engine v1.0.0
Condition
- CKD documented
- anemia present
What it reports
- Iron indices should be assessed before an erythropoiesis-stimulating agent is considered
- KDIGO 2012 suggests a trial of iron when transferrin saturation ≤30% and ferritin ≤500 ng/mL in anemic CKD patients not on iron
Diagnostic boundary
- ESA and iron decisions belong to the treating physician or nephrologist.
Evidence
- EV-KDIGO-ANEMIA-2012KDIGO Anemia Work Group. KDIGO Clinical Practice Guideline for Anemia in Chronic Kidney Disease. Kidney Int Suppl. 2012;2(4):279-335.Supports: Assess iron status before ESA therapy Iron trial in anemic CKD with transferrin saturation ≤30% and ferritin ≤500 ng/mL
Cases where this rule fires
Open a case to see this rule fire with real inputs, then change the values until it stops.
Try Biod in your practice
The Clinical Intelligence Layer — transforming fragmented clinical information into structured intelligence for clinician review and action.